Home » FDA Accepts Medarex Filing to Develop New Cancer Drug
FDA Accepts Medarex Filing to Develop New Cancer Drug
Medarex Inc., a biopharmaceutical company … announced that the Food & Drug Administration has accepted its application for an investigational new drug to treat renal cell carcinoma and non-Hodgkin’s lymphoma.
NJBIZ
NJBIZ
Upcoming Events
-
07May
-
14May
-
30May